FDA Recalls Methocarbamol Tablets Due to Presence of Hair
Golden State Medical Supply Inc. is recalling 1,165 bottles of Methocarbamol 500 mg tablets because they contain hair.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 1/5 (Low).
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which by definition is unlikely to cause adverse health consequences, and the hazard is a cosmetic/foreign substance issue without reported injuries.
Plain-English summary
Golden State Medical Supply Inc. is recalling 1,165 bottles of Methocarbamol Tablets, USP 500 mg, 500 Count Bottles, Rx Only. The recall is due to the presence of a foreign substance, specifically hair, in the product.
The affected product is identified by Lot # GS007849 with an expiry date of 02/2017. The tablets were manufactured by AustarPharma LLC and packaged by GSMS Incorporated. The distribution pattern includes the U.S., specifically Georgia.
Consumers should check their inventory for this specific lot number and contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- METHOCARBAMOL TABLETS, USP 500 mg, 500 Count Bottles, Rx Only. Manufactured by AustarPharma LLC, Edison, NJ 08837, USA, Packaged by GSMS Incorporated, Camarillo, CA 93012, USA, NDC: 60429-118-05.
- Manufacturer
- Golden State Medical Supply Inc.
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 1,165
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # GS007849
- Expiry: 02/2017
Distribution
Distributed in 1 state:
Related recalls
Same manufacturer · Golden State Medical Supply Inc.
See all →- SevereGolden State Medical Supply Recalls Prasugrel Tablets for Failed Dissolution
FDA (Drugs) · 2026-09-09
- ModerateGolden State Medical Supply Recalls Carbamazepine Tablets Due to CGMP Deviations
FDA (Drugs) · 2026-08-26
- ModerateNiacin extended-release tablets failed dissolution testing at 24 hours
FDA (Drugs) · 2026-06-17
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- ModeratePrimidone Tablets Recalled Due to API Cross-Contamination
FDA (Drugs) · 2026-05-27
Same hazard · foreign substance
See all →- ModerateHeritage Pharmaceuticals Recalls Clindamycin Palmitate Hydrochloride Due to Foreign Particles
FDA (Drugs) · 2026-08-19
- HighPrednisolone Acetate Ophthalmic Suspension Recalled for Foreign Substance
FDA (Drugs) · 2026-07-08
- ModerateCorlanor Ivabradine Tablets Recalled for Foreign Substance Contamination
FDA (Drugs) · 2026-07-01
- LowHydroxyzine Hydrochloride Oral Solution recalled for foreign substance
FDA (Drugs) · 2026-07-01
- ModerateCorlanor ivabradine tablets recalled for presence of foreign substance
FDA (Drugs) · 2026-07-01
Similar recalls
- SevereLosartan Potassium Tablets Recalled for Presence of Foreign Substance Debris
FDA (Drugs) · 2014-06-11
- ModerateGolden State Medical Supply Recalls Carbamazepine Tablets Due to CGMP Deviations
FDA (Drugs) · 2026-08-26
- SevereMetoclopramide Tablets Recalled for Presence of Foreign Tablets
FDA (Drugs) · 2025-07-02
- SevereZydus Recalls Metformin Tablets Due to Foreign Substance Presence
FDA (Drugs) · 2012-08-08
- ModerateSun Pharmaceutical Recalls Metformin Hydrochloride Tablets Due to Foreign Matter
FDA (Drugs) · 2018-07-25
- LowHetero USA Recalls Acyclovir Tablets Due to Human Hair Presence
FDA (Drugs) · 2017-06-14